Intraocular pressure reducing 9,15-diacyl prostaglandins

Details Intraocular pressure reducing 9,15-diacyl prostaglandins Intraocular pressure reducing 9,15-diacyl prostaglandins

1990-09-18

1991-07-02

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514913, A61K 31215

Patent

active

050286242

ABSTRACT:
Disclosed is an intraocular pressure reducing method and composition wherein 9,15-diacyl prostaglandins are contained in a pharmaceutically acceptable excipient for topical application on the surface of the eye.

REFERENCES:
patent: 4001306 (1977-01-01), Morozowich et al.
patent: 4060540 (1977-11-01), Bernady et al.
patent: 4599353 (1986-07-01), Bito
patent: 4822819 (1989-04-01), DeSantis et al.
patent: 4824857 (1989-04-01), Goh et al.
patent: 4883819 (1989-11-01), Bito, II
Starr, Exp. Eye Res. 11, 170-177 (1971).
Zajacz et al., The Eye: Reproduction, Obstetrics and Gynecology 4, 316 (1976).
Keun Kim Investigative Ophthalmology 14, 36 (1975).
Camras et al., Invest. Ophthalmol. Visual Sci. 16, 1125 (1977).
Woodward et al., Invest. Ophthalmol. Visual Sci. 30, 1838 (1989).
Nilsson et al., Exp. Eye Res. 48, 707 (1989).
Bito, Arch. Ophthalmol. 105, 1036 (1987).
Siebold et al., Prodrug. 5, 3 (1989).

Affiliated with

Also associated with

Rating

Intraocular pressure reducing 9,15-diacyl prostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intraocular pressure reducing 9,15-diacyl prostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular pressure reducing 9,15-diacyl prostaglandins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1247547